Bagante, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 3.356
EU - Europa 3.353
AS - Asia 1.095
AF - Africa 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 7.831
Nazione #
US - Stati Uniti d'America 3.341
GB - Regno Unito 1.145
CN - Cina 992
IT - Italia 588
IE - Irlanda 403
SE - Svezia 350
FR - Francia 336
DE - Germania 239
FI - Finlandia 102
UA - Ucraina 89
TR - Turchia 62
BE - Belgio 18
NL - Olanda 16
VN - Vietnam 15
AT - Austria 13
CA - Canada 11
CH - Svizzera 11
RU - Federazione Russa 11
RO - Romania 8
EU - Europa 7
IN - India 7
BR - Brasile 5
SC - Seychelles 5
KR - Corea 4
AU - Australia 3
ES - Italia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
EE - Estonia 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
MX - Messico 2
NO - Norvegia 2
PL - Polonia 2
RS - Serbia 2
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
Totale 7.831
Città #
Southend 1.100
Chandler 704
Dublin 401
Jacksonville 399
Woodbridge 320
Beijing 236
Ashburn 203
Ann Arbor 160
Houston 156
Lawrence 150
Princeton 150
Wilmington 135
Verona 113
Nanjing 93
Jinan 89
Shenyang 68
New York 66
Helsinki 53
Tianjin 49
Sindelfingen 46
Hebei 42
Ningbo 36
Nanchang 34
Redwood City 31
Changsha 30
Seattle 29
Norwalk 27
Falls Church 26
Taizhou 26
Zhengzhou 24
Rome 22
Haikou 21
Milan 21
Hangzhou 20
Cambridge 17
Taiyuan 17
Washington 17
Guangzhou 16
Jiaxing 15
Brussels 14
Boardman 13
Dong Ket 13
Redmond 13
Bologna 12
Zurich 11
Düsseldorf 10
Fairfield 10
Lanzhou 10
Vienna 10
Cagliari 9
Fuzhou 8
Lancaster 8
Chicago 7
Napoli 7
Dongguan 6
Esslingen am Neckar 6
Florence 6
San Diego 6
Dearborn 5
Padova 5
Toronto 5
Arona 4
Auburn 4
Bari 4
Como 4
Kemerovo 4
Palermo 4
Paris 4
San Francisco 4
Stockholm 4
Timisoara 4
Venezia 4
Waanrode 4
Wuhan 4
Bolzano 3
Brescia 3
Detroit 3
Edinburgh 3
Groningen 3
Gunzenhausen 3
Lappeenranta 3
Naaldwijk 3
Nürnberg 3
Perugia 3
Qingdao 3
Seoul 3
Torino 3
Villafranca Di Verona 3
Amsterdam 2
Avellino 2
Berlin 2
Bratislava 2
Capaccio 2
Casablanca 2
Castelnuovo Rangone 2
Chongqing 2
Cinisello Balsamo 2
Columbus 2
Desio 2
Dubai 2
Totale 5.474
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 376
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 179
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 151
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 111
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 107
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 106
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 106
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 106
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 105
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 104
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 102
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 100
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 94
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 90
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 88
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 86
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 84
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 83
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 81
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 79
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 79
Cholangiocarcinoma risk factors and the potential role of aspirin 79
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 77
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 77
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 77
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 76
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 76
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 75
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 75
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 73
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 73
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 72
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 71
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 70
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 69
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 68
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 67
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 66
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 66
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 66
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 65
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 64
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 63
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 62
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 62
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 62
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 61
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 61
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 60
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 60
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 60
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 59
Central Pancreatectomy: from Open to Minimally Invasive 56
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 56
Primary liver cancer: Prognostic factors and predictive response to therapy 55
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 54
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 54
Quality of life after treatment of neuroendocrine liver metastasis 54
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 54
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 52
Complications after liver surgery: a benchmark analysis 52
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 51
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 51
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 51
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 51
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 51
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 50
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 49
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 48
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 47
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 47
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma 46
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 46
Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan 45
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 45
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 44
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 44
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 44
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients 44
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 43
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 43
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 42
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 42
Perioperative use of blood products is associated with risk of morbidity and mortality after surgery 42
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? 41
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 41
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 41
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 40
Liver transplantation in patients with liver metastases from neuroendocrine tumors 40
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 39
Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma 38
Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers 38
The impact of a malignant diagnosis on the pattern and outcome of readmission after liver and pancreatic surgery: An analysis of the nationwide readmissions database 38
Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score 38
Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis 38
Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery 37
Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma 36
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 36
Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma 35
Impact of skilled nursing facility quality on postoperative outcomes after pancreatic surgery 35
Totale 6.693
Categoria #
all - tutte 30.261
article - articoli 28.466
book - libri 0
conference - conferenze 1.188
curatela - curatele 0
other - altro 209
patent - brevetti 0
selected - selezionate 0
volume - volumi 398
Totale 60.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 6 8 5
2019/2020866 123 40 12 37 96 105 115 27 36 45 88 142
2020/20211.208 149 165 32 177 183 145 18 43 79 30 143 44
2021/2022917 106 165 25 63 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/2024894 54 93 105 103 159 195 43 112 6 24 0 0
Totale 8.038